Home › Companies › CORCEPT THERAPEUTICS INC. › 2023-2024

CORCEPT THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and CORCEPT THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

12Ballot items
299Asset managers
3,686Fund votes
May 17, 2024Meeting date

Results at a glance

Meeting of May 17, 2024: 12 items on CORCEPT THERAPEUTICS INC.’s Form 8-K, filed May 23, 2024: 9 elected · 3 approved.

Material dissent

4. Corcept Therapeutics Incorporated 2024 Incentive Award Plan 72% of votes cast Approved Under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CORCEPT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CORCEPT THERAPEUTICS INC.

These tallies are CORCEPT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORCEPT THERAPEUTICS INC. — official shareholder meeting results, meeting held May 17, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Gregg Alton	60,315,939	--	--	5,562,189	22,496,236	92%	Elected	—
Elect Director: G. Leonard Baker, Jr.	62,443,392	--	--	3,434,736	22,496,236	95%	Elected	—
Elect Director: Joseph K. Belanoff, M.D.	65,590,721	--	--	287,407	22,496,236	99.5%	Elected	—
Elect Director: Gillian M. Cannon, Ph.D.	63,808,757	--	--	2,004,740	22,560,867	97%	Elected	—
Elect Director: David L. Mahoney	64,919,195	--	--	958,933	22,496,236	99%	Elected	—
Elect Director: Joshua M. Murray	65,624,110	--	--	254,018	22,496,236	99.6%	Elected	—
Elect Director: Kimberly Park	56,969,410	--	--	8,908,718	22,496,236	86%	Elected	—
Elect Director: Daniel N. Swisher, Jr.	65,622,142	--	--	255,986	22,496,236	99.6%	Elected	—
Elect Director: James N. Wilson	62,619,695	--	--	3,258,433	22,496,236	95%	Elected	—
2. Appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024	86,596,528	1,707,066	70,770	--	--	98%	Approved	—
3. Compensation of named executive officers	64,501,372	1,018,089	358,666	--	22,496,237	98%	Approved	—
4. Corcept Therapeutics Incorporated 2024 Incentive Award Plan	47,018,093	18,698,799	161,233	--	22,496,239	72%	Approved	—

Source: CORCEPT THERAPEUTICS INC., Form 8-K, filed with the SEC on May 23, 2024 — read the filing on EDGAR.

How asset managers voted at the CORCEPT THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 299 asset managers that disclosed a CORCEPT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: David L. Mahoney

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 64,919,195WITHHELD: 958,933

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: David L. Mahoney

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: David L. Mahoney”): 64,919,195 for, 958,933 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,774,998 for, 59,126 withheld, 12,023 abstained.

FOR

FOR: 27,774,998ABSTAIN: 12,023WITHHOLD: 59,126

Largest asset managers voting on “Election of Directors: David L. Mahoney” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,390,914	0	0	For
BlackRock	6,720,489	0	0	For
First Trust	1,830,396	0	0	For
Dimensional	1,618,776	0	0	For
State Street	1,552,703	0	3,491	For
Charles Schwab	898,696	0	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	0	For
Fidelity	662,010	0	0	For
Legg Mason	417,236	0	0	For
Royce	331,800	0	0	For
Jackson National	282,371	0	0	For
Columbia Threadneedle	246,005	0	0	For
Equitable	219,977	0	0	For
TIAA	215,614	0	0	For
Janus Detroit Street Trust	202,124	0	0	For
ETF Series Solutions	166,277	12,023	0	Mixed
QUANTITATIVE MASTER SERIES LLC	151,815	0	0	For
American Century	143,440	0	0	For
BNY Mellon	137,568	0	0	For
MoA Funds Corp	133,329	0	0	For
Lincoln Financial	113,556	0	0	For
Principal	104,314	0	0	For
AllianceBernstein	98,204	0	0	For
Guardian Variable Products Trust	93,600	0	0	For
Thrivent	77,912	0	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

2. Elect Director: G. Leonard Baker, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 62,443,392WITHHELD: 3,434,736

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: G. Leonard Baker, Jr.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 62,443,392 for, 3,434,736 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,349,835 for, 484,289 withheld, 12,023 abstained.

FOR

FOR: 27,349,835ABSTAIN: 12,023WITHHOLD: 484,289

Largest asset managers voting on “Election of Directors: G. Leonard Baker, Jr.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,390,914	0	0	For
BlackRock	6,720,489	0	0	For
First Trust	1,830,396	0	0	For
Dimensional	1,618,776	0	0	For
State Street	1,551,134	0	5,060	For
Charles Schwab	898,696	0	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	0	For
Fidelity	662,010	0	0	For
Legg Mason	417,236	0	0	For
Royce	331,800	0	0	For
Jackson National	282,371	0	0	For
Columbia Threadneedle	0	0	246,005	Withhold
Equitable	219,977	0	0	For
TIAA	215,614	0	0	For
Janus Detroit Street Trust	202,124	0	0	For
ETF Series Solutions	166,277	12,023	0	Mixed
QUANTITATIVE MASTER SERIES LLC	151,815	0	0	For
American Century	143,440	0	0	For
BNY Mellon	137,568	0	0	For
MoA Funds Corp	133,329	0	0	For
Lincoln Financial	113,556	0	0	For
Principal	104,314	0	0	For
AllianceBernstein	98,204	0	0	For
Guardian Variable Products Trust	93,600	0	0	For
Thrivent	77,912	0	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

3. Elect Director: Gillian M. Cannon, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 63,808,757WITHHELD: 2,004,740

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: Gillian M. Cannon, Ph.D.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gillian M. Cannon, Ph.D.”): 63,808,757 for, 2,004,740 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,777,811 for, 68,336 withheld.

FOR

FOR: 27,777,811WITHHOLD: 68,336

Largest asset managers voting on “Election of Directors: Gillian M. Cannon, Ph.D.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	9,390,914	0	For
BlackRock	6,720,489	0	For
First Trust	1,830,396	0	For
Dimensional	1,618,776	0	For
State Street	1,552,310	3,884	For
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	662,010	0	For
Legg Mason	417,236	0	For
Royce	331,800	0	For
Jackson National	282,371	0	For
Columbia Threadneedle	246,005	0	For
Equitable	219,977	0	For
TIAA	215,614	0	For
Janus Detroit Street Trust	202,124	0	For
ETF Series Solutions	178,300	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	143,440	0	For
BNY Mellon	137,568	0	For
MoA Funds Corp	133,329	0	For
Lincoln Financial	113,556	0	For
Principal	104,314	0	For
AllianceBernstein	98,204	0	For
Guardian Variable Products Trust	93,600	0	For
Thrivent	77,912	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

4. Elect Director: Gregg Alton

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%

FOR: 60,315,939WITHHELD: 5,562,189

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: Gregg Alton

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Alton”): 60,315,939 for, 5,562,189 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 24,497,541 for, 3,313,417 withheld, 35,189 abstained.

FOR

FOR: 24,497,541ABSTAIN: 35,189WITHHOLD: 3,313,417

Largest asset managers voting on “Election of Directors: Gregg Alton” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,390,914	0	0	For
BlackRock	6,720,489	0	0	For
First Trust	1,830,396	0	0	For
Dimensional	0	0	1,618,776	Withhold
State Street	25,394	0	1,530,800	Withhold
Charles Schwab	898,696	0	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	0	For
Fidelity	662,010	0	0	For
Legg Mason	417,236	0	0	For
Royce	331,800	0	0	For
Jackson National	259,429	22,942	0	Mixed
Columbia Threadneedle	246,005	0	0	For
Equitable	219,977	0	0	For
TIAA	215,614	0	0	For
Janus Detroit Street Trust	202,124	0	0	For
ETF Series Solutions	178,300	0	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	0	For
American Century	143,440	0	0	For
BNY Mellon	137,568	0	0	For
MoA Funds Corp	133,329	0	0	For
Lincoln Financial	36,283	0	77,273	Mixed
Principal	104,079	0	235	For
AllianceBernstein	98,204	0	0	For
Guardian Variable Products Trust	93,600	0	0	For
Thrivent	77,912	0	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

5. Elect Director: James N. Wilson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 62,619,695WITHHELD: 3,258,433

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: James N. Wilson

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: James N. Wilson”): 62,619,695 for, 3,258,433 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,349,835 for, 484,289 withheld, 12,023 abstained.

FOR

FOR: 27,349,835ABSTAIN: 12,023WITHHOLD: 484,289

Largest asset managers voting on “Election of Directors: James N. Wilson” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,390,914	0	0	For
BlackRock	6,720,489	0	0	For
First Trust	1,830,396	0	0	For
Dimensional	1,618,776	0	0	For
State Street	1,551,134	0	5,060	For
Charles Schwab	898,696	0	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	0	For
Fidelity	662,010	0	0	For
Legg Mason	417,236	0	0	For
Royce	331,800	0	0	For
Jackson National	282,371	0	0	For
Columbia Threadneedle	0	0	246,005	Withhold
Equitable	219,977	0	0	For
TIAA	215,614	0	0	For
Janus Detroit Street Trust	202,124	0	0	For
ETF Series Solutions	166,277	12,023	0	Mixed
QUANTITATIVE MASTER SERIES LLC	151,815	0	0	For
American Century	143,440	0	0	For
BNY Mellon	137,568	0	0	For
MoA Funds Corp	133,329	0	0	For
Lincoln Financial	113,556	0	0	For
Principal	104,314	0	0	For
AllianceBernstein	98,204	0	0	For
Guardian Variable Products Trust	93,600	0	0	For
Thrivent	77,912	0	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

6. Elect Director: Joseph K. Belanoff, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 65,590,721WITHHELD: 287,407

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: Joseph K. Belanoff, M.D.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 65,590,721 for, 287,407 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,806,378 for, 39,769 withheld.

FOR

FOR: 27,806,378WITHHOLD: 39,769

Largest asset managers voting on “Election of Directors: Joseph K. Belanoff, M.D.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	9,390,914	0	For
BlackRock	6,720,489	0	For
First Trust	1,830,396	0	For
Dimensional	1,618,776	0	For
State Street	1,553,560	2,634	For
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	662,010	0	For
Legg Mason	417,236	0	For
Royce	331,800	0	For
Jackson National	282,371	0	For
Columbia Threadneedle	246,005	0	For
Equitable	219,977	0	For
TIAA	215,614	0	For
Janus Detroit Street Trust	202,124	0	For
ETF Series Solutions	178,300	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	143,440	0	For
BNY Mellon	137,568	0	For
MoA Funds Corp	133,329	0	For
Lincoln Financial	113,556	0	For
Principal	104,314	0	For
AllianceBernstein	98,204	0	For
Guardian Variable Products Trust	93,600	0	For
Thrivent	77,912	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

7. Elect Director: Joshua M. Murray

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 65,624,110WITHHELD: 254,018

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: Joshua M. Murray

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joshua M. Murray”): 65,624,110 for, 254,018 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 27,792,792 for, 53,355 withheld.

FOR

FOR: 27,792,792WITHHOLD: 53,355

Largest asset managers voting on “Election of Directors: Joshua M. Murray” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	9,390,914	0	For
BlackRock	6,720,489	0	For
First Trust	1,830,396	0	For
Dimensional	1,618,776	0	For
State Street	1,553,879	2,315	For
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	662,010	0	For
Legg Mason	417,236	0	For
Royce	331,800	0	For
Jackson National	282,371	0	For
Columbia Threadneedle	246,005	0	For
Equitable	219,977	0	For
TIAA	215,614	0	For
Janus Detroit Street Trust	202,124	0	For
ETF Series Solutions	178,300	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	143,440	0	For
BNY Mellon	137,568	0	For
MoA Funds Corp	133,329	0	For
Lincoln Financial	113,556	0	For
Principal	104,314	0	For
AllianceBernstein	98,204	0	For
Guardian Variable Products Trust	93,600	0	For
Thrivent	77,912	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

8. Elect Director: Kimberly Park

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%

FOR: 56,969,410WITHHELD: 8,908,718

Details: description as filed, official tally, votes by 91 asset managers

Description as filed by funds: Election of Directors: Kimberly Park

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kimberly Park”): 56,969,410 for, 8,908,718 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 91 asset managers below reported 24,058,993 for, 3,741,610 withheld, 45,544 abstained.

FOR

FOR: 24,058,993ABSTAIN: 45,544WITHHOLD: 3,741,610

Largest asset managers voting on “Election of Directors: Kimberly Park” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,390,914	0	0	For
BlackRock	6,720,489	0	0	For
First Trust	1,830,396	0	0	For
Dimensional	0	0	1,618,776	Withhold
State Street	23,825	0	1,532,369	Withhold
Charles Schwab	898,696	0	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	0	For
Fidelity	662,010	0	0	For
Legg Mason	417,236	0	0	For
Royce	331,800	0	0	For
Jackson National	259,429	22,942	0	Mixed
Columbia Threadneedle	0	0	246,005	Withhold
Equitable	219,977	0	0	For
TIAA	215,614	0	0	For
Janus Detroit Street Trust	202,124	0	0	For
ETF Series Solutions	178,300	0	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	0	For
American Century	143,440	0	0	For
BNY Mellon	137,568	0	0	For
MoA Funds Corp	133,329	0	0	For
Lincoln Financial	36,283	0	77,273	Mixed
Principal	104,314	0	0	For
AllianceBernstein	98,204	0	0	For
Guardian Variable Products Trust	93,600	0	0	For
Thrivent	77,912	0	0	For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

9. Elect Director: Daniel N. Swisher, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 65,622,142WITHHELD: 255,986

Details: description as filed, official tally, votes by 90 asset managers

Description as filed by funds: Election of Directors: Daniel N. Swisher, Jr.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 65,622,142 for, 255,986 withheld, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2025 annual meeting of stockholders.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 90 asset managers below reported 27,782,792 for, 53,355 withheld.

FOR

FOR: 27,782,792WITHHOLD: 53,355

Largest asset managers voting on “Election of Directors: Daniel N. Swisher, Jr.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Withheld	Vote
Vanguard	9,390,914	0	For
BlackRock	6,720,489	0	For
First Trust	1,830,396	0	For
Dimensional	1,618,776	0	For
State Street	1,553,879	2,315	For
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	662,010	0	For
Legg Mason	417,236	0	For
Royce	331,800	0	For
Jackson National	282,371	0	For
Columbia Threadneedle	246,005	0	For
Equitable	219,977	0	For
TIAA	215,614	0	For
Janus Detroit Street Trust	202,124	0	For
ETF Series Solutions	178,300	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	143,440	0	For
BNY Mellon	137,568	0	For
MoA Funds Corp	133,329	0	For
Lincoln Financial	113,556	0	For
Principal	104,314	0	For
AllianceBernstein	98,204	0	For
Guardian Variable Products Trust	93,600	0	For
Thrivent	77,912	0	For

Showing the 25 largest of 90 asset managers. See all 90 in the interactive database.

10. 4. Corcept Therapeutics Incorporated 2024 Incentive Award Plan

Official resultCOMPENSATIONReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

72% Approved · of votes cast

FOR 72%AGAINST

FOR: 47,018,093AGAINST: 18,698,799

Details: description as filed, official tally, votes by 90 asset managers

Description as filed by funds: To approve the Corcept Therapeutics Incorporated 2024 Incentive Award Plan.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“4. Corcept Therapeutics Incorporated 2024 Incentive Award Plan”): 47,018,093 for, 18,698,799 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - The Corcept Therapeutics Incorporated 2024 Incentive Award Plan was approved.”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 90 asset managers below reported 19,082,904 for, 8,683,345 against.

FORAGAINST

FOR: 19,082,904AGAINST: 8,683,345

Largest asset managers voting on “To approve the Corcept Therapeutics Incorporated 2024 Incentive Award Plan.” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	9,323,314	67,600	For
BlackRock	6,720,489	0	For
First Trust	0	1,830,396	Against
Dimensional	0	1,618,776	Against
State Street	10,140	1,546,054	Against
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	633,219	28,791	For
Legg Mason	0	417,236	Against
Royce	0	331,800	Against
Jackson National	0	282,371	Against
Columbia Threadneedle	0	246,005	Against
Equitable	125,817	94,160	Mixed
TIAA	0	215,614	Against
Janus Detroit Street Trust	0	202,124	Against
ETF Series Solutions	21,398	156,902	Mixed
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	0	143,440	Against
BNY Mellon	0	137,568	Against
MoA Funds Corp	0	133,329	Against
Lincoln Financial	0	113,556	Against
Principal	235	104,079	Against
AllianceBernstein	0	98,204	Against
Guardian Variable Products Trust	0	93,600	Against
Thrivent	0	77,912	Against

Showing the 25 largest of 90 asset managers. See all 90 in the interactive database.

11. 3. Compensation of named executive officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 64,501,372AGAINST: 1,018,089

Details: description as filed, official tally, votes by 298 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“3. Compensation of named executive officers”): 64,501,372 for, 1,018,089 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 91 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	9,390,914	0	For
BlackRock	6,720,489	0	For
First Trust	1,830,396	0	For
Dimensional	1,618,776	0	For
State Street	1,556,194	0	For
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	662,010	0	For
Legg Mason	417,236	0	For
Royce	331,800	0	For
Jackson National	282,371	0	For
Columbia Threadneedle	246,005	0	For
Equitable	219,977	0	For
TIAA	215,614	0	For
Janus Detroit Street Trust	202,124	0	For
ETF Series Solutions	178,300	0	For
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	0	143,440	Against
BNY Mellon	137,568	0	For
MoA Funds Corp	133,329	0	For
Lincoln Financial	113,556	0	For
Principal	104,314	0	For
AllianceBernstein	98,204	0	For
Guardian Variable Products Trust	93,600	0	For
Thrivent	77,912	0	For

Fund voting reports, all 91 managers: 27,663,210 for, 152,298 against, 37,135 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 235 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Man Group plc	10,751,900	0	For
State Street	3,175,388	0	For
BlackRock	2,443,498	987	For
Novo Holdings A/S	2,411,362	0	For
Charles Schwab	939,662	0	For
Boston Trust Walden Co	762,717	0	For
Renaissance	726,046	0	For
GEODE CAPITAL MANAGEMENT, LLC	623,025	0	For
Northern Trust	593,129	55	For
MELLON INVESTMENTS Corp	586,192	0	For
PRINCIPAL GLOBAL INVESTORS	526,344	0	For
Clearbridge Investments, LLC	525,267	0	For
Two Sigma	478,185	0	For
Cyrus J. Lawrence, LLC	460,000	0	For
Cerity Partners LLC	396,941	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	338,285	2,123	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	294,098	0	For
Stewart Capital Advisors, LLC	269,680	0	For
Point72	250,985	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	243,512	0	For
Vanguard	240,339	0	For
Janus Henderson	219,530	0	For
Nuveen	219,037	0	For
Allianz	0	205,284	Against
AllianceBernstein	194,764	0	For

Institutional-manager reports, all 235 managers: 32,367,691 for, 858,437 against, 5 abstained, 28,703 not voted. Showing the 25 largest; see all in the interactive database.

12. 2. Appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 86,596,528AGAINST: 1,707,066

Details: description as filed, official tally, votes by 94 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“2. Appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024”): 86,596,528 for, 1,707,066 against — passed, per its Form 8-K filed May 23, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 94 asset managers below reported 27,804,028 for, 13,749 against, 37,135 abstained.

FOR

FOR: 27,804,028AGAINST: 13,749ABSTAIN: 37,135

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm ” at CORCEPT THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	9,390,914	0	For
BlackRock	6,720,489	0	For
First Trust	1,830,396	0	For
Dimensional	1,618,776	0	For
State Street	1,555,018	1,176	For
Charles Schwab	898,696	0	For
BOSTON TRUST WALDEN FUNDS	763,075	0	For
Fidelity	662,010	0	For
Legg Mason	417,236	0	For
Royce	331,800	0	For
Jackson National	282,371	0	For
Columbia Threadneedle	246,005	0	For
Equitable	219,977	0	For
TIAA	215,614	0	For
Janus Detroit Street Trust	202,124	0	For
ETF Series Solutions	166,277	12,023	Mixed
QUANTITATIVE MASTER SERIES LLC	151,815	0	For
American Century	143,440	0	For
BNY Mellon	137,568	0	For
MoA Funds Corp	133,329	0	For
Lincoln Financial	113,556	0	For
Principal	104,314	0	For
AllianceBernstein	98,204	0	For
Guardian Variable Products Trust	93,600	0	For
Thrivent	77,912	0	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

Largest CORCEPT THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 103,405,000 shares outstanding at the time of that meeting.

Fund voting reports: top CORCEPT THERAPEUTICS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers as…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	9.08%
2	BlackRock	6.50%
3	First Trust	1.77%
4	Dimensional	1.57%
5	State Street	1.50%
6	Charles Schwab	0.87%
7	BOSTON TRUST WALDEN FUNDS	0.74%
8	Fidelity	0.64%
9	Legg Mason	0.40%
10	Royce	0.32%

Institutional-manager reports: top CORCEPT THERAPEUTICS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers as…”, 2023-2024
#	Asset manager	% of shares outstanding
1	Man Group plc	10.40%
2	State Street	3.07%
3	BlackRock	2.36%
4	Novo Holdings A/S	2.33%
5	Charles Schwab	0.94%
6	Boston Trust Walden Co	0.74%
7	Renaissance	0.70%
8	GEODE CAPITAL MANAGEMENT, LLC	0.60%
9	Northern Trust	0.57%
10	MELLON INVESTMENTS Corp	0.57%

Reported CORCEPT THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

CORCEPT THERAPEUTICS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	11.65%	13F
Vanguard Group	9.22%	13F
Ingalls & Snyder, LLC and affiliated entities	7.99%	DEF14A
Renaissance Technologies	6.50%	DEF14A
Joseph K. Belanoff, M.D.	6.50%	DEF14A
G. Leonard Baker, Jr.	5.33%	13G
State Street	3.46%	13F
James N. Wilson	2.96%	DEF14A
Dimensional Fund Advisors	2.48%	13F
FMR (Fidelity)	2.13%	13F

Percentages above are of 103,405,000 shares outstanding, as reported by CORCEPT THERAPEUTICS INC. on its Form 10-K dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORCEPT THERAPEUTICS INC.’s 10-K dated December 31, 2023. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At CORCEPT THERAPEUTICS INC.'s shareholder meeting held May 17, 2024, in the 2023-2024 proxy season, 299 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 3,686 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — CORCEPT THERAPEUTICS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CORCEPT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2024.

CORCEPT THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.